Zobrazeno 1 - 9 of 9 pro vyhledávání: '"I. Cuenca Cuenca"'
1
Individualized dosimetry for patients with graves’ disease
Autor: F.J. Luis Simón, D. Jimenez Felstrom, E. Lopez Rodriguez, I. Cuenca Cuenca
Publikováno v: Physica Medica. 32:318
Introduction Following Directive 2013/59 Euratom, all therapeutic exposures of target volumes shall be individually planned and their delivery appropriately verified. We have developed a home-made software for I-131 dosimetry in hyperthyroid patients
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2a731432118d676e87700ce25560d1c0
https://doi.org/10.1016/j.ejmp.2016.07.200
Zobrazit plný text záznamu
2
123I-MIBG, 18F-DOPA and 18F-FDG in a patient with MEN2 syndrome and recurrent pheochromocytoma
Autor: J I, Cuenca-Cuenca, V A, Marín-Oyaga, I, Borrego-Dorado, E, Navarro-González, J M, Martos-Martínez, R, Vázquez-Albertino
Publikováno v: Revista espanola de medicina nuclear e imagen molecular. 32(4)
Pheochromocytoma is a rare tumor located in the medulla of the adrenal gland that is characterized by high catecholamine synthesis. Surgery is the treatment of choice and is usually curative if appropriately diagnosed and excised. Imaging methods, bo
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::4f95faa5809f2b1c708949edf7ae71e0
https://pubmed.ncbi.nlm.nih.gov/23434017
Zobrazit plný text záznamu
3
[Unsuspected bronchial carcinoid tumor detected in a somatostatin receptor scintigraphy in a patient with multiple endocrine neoplasia syndrome type 1 and hypergastrinemia]
Autor: V, Marín-Oyaga, J L, Tirado-Hospital, J I, Cuenca-Cuenca, R, Guerrero-Vázquez, D, Luján-Rodríguez, R, Vázquez-Albertino
Publikováno v: Revista espanola de medicina nuclear e imagen molecular. 32(2)
Multiple Endocrine Neoplasia type 1 syndrome (MEN1) is characterized by the presence of tumors in parathyroid glands, anterior pituitary gland, endocrine pancreas and duodenum. However, other tumors may also occur. One of them is the carcinoid tumor,
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::5a940da1c6841d54e7ca5c085dae4a99
https://pubmed.ncbi.nlm.nih.gov/23099067
Zobrazit plný text záznamu
5
Value of the negative PET-FDG in the middle term follow-up of differentiated thyroid cancer in patients with negative 131 I-Na scan and elevated thyroglobulin serum levels
Autor: V M, Pachón-Garrudo, J I, Cuenca-Cuenca, J, Ruiz-Franco-Baux, I, Borrego-Dorado, J L, Tirado-Hospital, E, Navarro-González, R, Vázquez-Albertino
Publikováno v: Revista espanola de medicina nuclear e imagen molecular. 31(6)
This study has aimed to analyze the evolution of patients diagnosed with differentiated thyroid carcinoma (DTC) with a negative (131)I-Na whole body scan (WBS), high levels of serum thyroglobulin (Tg) and negative (18F)fluorodeoxyglucose positron emi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::548d7ea99403bd522dc2501f673d5a61
https://pubmed.ncbi.nlm.nih.gov/23084014
Zobrazit plný text záznamu
7
[Evaluation of efficacy and clinical impact of 18F-FDG-PET in the diagnosis of recurrent medullary thyroid cancer with increased calcitonin and negative imaging test]
Autor: P, Gómez-Camarero, A, Ortiz-de Tena, I, Borrego-Dorado, R J, Vázquez-Albertino, E, Navarro-González, J V, Ruiz-Franco-Baux, J I, Cuenca-Cuenca
Publikováno v: Revista espanola de medicina nuclear e imagen molecular. 31(5)
To evaluate the efficacy and clinical impact of the FDG-PET in the diagnosis of suspicion of recurrence of medullary thyroid cancer (MTC) in patients with elevated serum calcitonin and negative imaging test.We performed a retrospective study of 31 co
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::cf8ebcac5b32cbfee9484d2cc002b98e
https://pubmed.ncbi.nlm.nih.gov/23067528
Zobrazit plný text záznamu
8
[Clinical impact of FDG-PET in patients with suspected recurrent ovarian cancer]
Autor: J I, Cuenca Cuenca, I, Borrego Dorado, R, Vázquez Albertino, P, Gómez Camarero, S, Sanz Viedma, R, Fernández López
Publikováno v: Revista espanola de medicina nuclear. 27(6)
To evaluate the efficacy and clinical impact of FDG-PET in patients with suspected recurrent ovarian cancer.Between October 2001 and October 2006, we retrospectively studied 49 FDG-PET performed in 40 women (age: 52.4 +/- 12.2 years) with ovarian can
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::38ea986c73d396899e69c37d8399350f
https://pubmed.ncbi.nlm.nih.gov/19094899
Zobrazit plný text záznamu
9
[Bone metastases from unknown primary. FDG-PET detection of two synchronous tumors]
Autor: J I, Cuenca Cuenca, I, Borrego Dorado, J R, Rodríguez Rodríguez, E, Navarro González, R, Vázquez Albertino
Publikováno v: Revista espanola de medicina nuclear. 26(5)
A 60-year-old woman presented with noncardiac chest pain over months and negative laboratory findings. Conventional imaging methods and bone scintigraphy detected bone lesions suggesting metastatic disease from an unknown primary tumor. An 18FDG-PET
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::3df3db9067b5e920357454e85de941ca
https://pubmed.ncbi.nlm.nih.gov/17910839
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje